Argenx
ARGX
#455
Rank
ยฃ40.90 B
Marketcap
ยฃ653.89
Share price
3.37%
Change (1 day)
56.17%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

ESG Reports

Thumbnail Argenx
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2021

ESG Report 2021

Language: English

View ESG Report